Hyundai invests in Aurora to develop driverless Kia & Hyundai models
Category: #business  By Mateen Dalal  Date: 2019-06-15
  • share
  • Twitter
  • Facebook
  • LinkedIn

Hyundai invests in Aurora to develop driverless Kia & Hyundai models
  • The investment intends to bring the startup’s innovative self-driving technology to a wider range of Kia and Hyundai vehicle models.
     
  • The Hyundai investment brings the total funding raised by the startup to approximately $700 million.

Hyundai Motor Company (Hyundai), a renowned South Korean multinational automobile manufacturer, has reportedly announced that it has invested in driverless car software startup, Aurora Innovation, Inc. (Aurora).

Reports cite, the investment intends to bring the startup’s innovative self-driving technology to a wider range of Kia and Hyundai automobiles models. The Hyundai investment brings the total funding raised by the startup to approximately $700 million.

According to a press release by Aurora, the investment is an extension to an existing partnership agreement that exists between Aurora and Hyundai & Kia that focuses on integrating Aurora Driver into Hyundai’s fuel-cell powered flagship vehicle, NEXO.

The Co-Founder & Chief Product Officer of Aurora, Sterling Anderson stated that the company’s primary aim is to work alongside its partners to bring the benefits of self-driving technology to more vehicles quickly, safely and broadly.

The investment does not make the company’s driverless technology exclusive to Hyundai and Kia and the startup aims to facilitate its innovative system to many different automobile industry players.

Recently, Aurora also signed a partnership agreement with Fiat Chrysler Automobiles to develop driverless vehicles for its corporate clients. Meanwhile, it is also working with a China-based electric vehicle manufacturer, Byton.

For the record, Aurora utilizes LIDAR or light detection and ranging sensors in its autonomous driving systems. The company’s approach is completely different than Tesla’s, which employs radar and cameras to primarily drive its Tesla Autopilot features.

Reportedly, apart from Hyundai, the list of the company’s investors also includes names such as Sequoia, Greylock, T. Rowe Price, Shell Energy’s venture capital group and tech giant Amazon.

According to reports, the total size of Hyundai’s investment in Aurora has not been disclosed yet.

 

Source:

https://www.cnbc.com/2019/06/12/hyundai-backs-aurora-to-bring-driverless-systems-to-kia-hyundai-cars.html

https://medium.com/aurora-blog/hyundai-and-kia-invest-in-aurora-6e1afbde609b

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More

More News By Mateen Dalal

AstraZenecas Farxiga gets fast track status to treat heart failure
AstraZenecas Farxiga gets fast track status to treat heart failure
By Mateen Dalal

With heart related issues and number of people diagnosed with heart failure increasing substantially, the need to find a solution to this problem is growing considerably. Advanced technology, equipment and pharmaceutical companies are continuously wo...

Upstream Works, Aceyus to pioneer customer experience solutions
Upstream Works, Aceyus to pioneer customer experience solutions
By Mateen Dalal

Customer Experience (CX) is vital for companies to understand the mindset of their clients. Industries are actively investing in customer experience solutions to stay ahead in competition. Companies are also partnering with other market players to en...

Patient data from Oncopeptides’ Phase 2 trial to be showcased at IMW
Patient data from Oncopeptides’ Phase 2 trial to be showcased at IMW
By Mateen Dalal

Patients having Relapsed-refractory multiple myeloma (RRMM) along with extramedullary disease (EMD) will be treated by Oncopeptides AB. In the company’s HORIZON trial, a cumulative response rate of 23% was attained with dexamethasone and mel...